These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 20553285

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The impact in Japan of regulatory action on prescribing of dopamine receptor agonists: analysis of a claims database between 2005 and 2008.
    Ooba N, Yamaguchi T, Kubota K.
    Drug Saf; 2011 Apr 01; 34(4):329-38. PubMed ID: 21417505
    [Abstract] [Full Text] [Related]

  • 9. Dopamine agonists, Dopplers and doubt: cabergoline-associated cardiac valvulopathy.
    Pullan PT.
    Intern Med J; 2009 Apr 01; 39(4):213-5. PubMed ID: 19402858
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cardiac valve regurgitation with pergolide compared with nonergot agonists in Parkinson disease.
    Dewey RB, Reimold SC, O'Suilleabhain PE.
    Arch Neurol; 2007 Mar 01; 64(3):377-80. PubMed ID: 17353380
    [Abstract] [Full Text] [Related]

  • 12. [Cardiac valvulopathy and dopamine agonist].
    Grandas F.
    Neurologia; 2007 Dec 01; 22(10):870-81. PubMed ID: 17671852
    [Abstract] [Full Text] [Related]

  • 13. Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists.
    Horvath J, Fross RD, Kleiner-Fisman G, Lerch R, Stalder H, Liaudat S, Raskoff WJ, Flachsbart KD, Rakowski H, Pache JC, Burkhard PR, Lang AE.
    Mov Disord; 2004 Jun 01; 19(6):656-62. PubMed ID: 15197703
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists.
    Kim JY, Chung EJ, Park SW, Lee WY.
    Mov Disord; 2006 Aug 01; 21(8):1261-4. PubMed ID: 16685692
    [Abstract] [Full Text] [Related]

  • 16. Dopamine agonists and cardiac valvulopathy in Parkinson disease: a case-control study.
    Senol MG, Togrol RE.
    Neurology; 2007 Jul 03; 69(1):117; author reply 117-8. PubMed ID: 17606893
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Heart abnormalities in Parkinson patients after discontinuation or continuation of ergot-derived dopamine agonists: a treatment-blinded echocardiographic study.
    Rasmussen VG, Poulsen SH, Dupont E, Østergaard K, Safikhany G, Egeblad H.
    J Heart Valve Dis; 2009 Jul 03; 18(4):463-9. PubMed ID: 19852154
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.